CLOV: Reynoso Jamie L. sold $9K of stock
By AlphaYouPublished Form 4
Reynoso Jamie L.
Reporting filer
Reynoso Jamie L. reported selling 2,006 shares of Clover Health Investments, Corp. /de for about $9K ($4.63 a share on average). Form 4 filed Oct 7, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 7, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Reynoso Jamie L. | 2026-10-07 | S | Sale | 2006 | 4.63 | 2,792,690 | 0 days | Filed terms
|
Class A Common Stock
- Owner
- Reynoso Jamie L.
- Date
- 2026-10-07
- Code
- S
- Action
- Sale
- Quantity
- 2006
- Price
- 4.63
- Following holdings
- 2,792,690
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Class A Common Stock
- transaction Date: 2026-10-07
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 2006
- id: F1
- transaction Price Per Share: 4.63
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 2792690
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Reynoso Jamie L.: CEO, Medicare Advantage.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
- F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Original sources
Prepared automatically from public filing data. Report a correction.